StockStory.org on MSN
PacBio (NASDAQ:PACB) misses Q1 CY2026 sales expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q1 CY2026, with sales flat year on year at $37.18 million ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) is among the 12 Best Genomics Stocks to Invest In. On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results